Patients With SGLT2 Inhibitor Therapy Can Reliably Measure Their Blood Glucose Without Interference Issues When Up-to-Date Potentiometric and Amperometric Blood Glucose Measurement Systems Are Used

2021 ◽  
pp. 193229682110503
Author(s):  
Kacia Mills ◽  
Julia Roetschke
Diabetes Care ◽  
1983 ◽  
Vol 6 (4) ◽  
pp. 422-422
Author(s):  
R. S. Clements ◽  
P. K. Fairclough

2016 ◽  
Vol 11 (2) ◽  
pp. 296-298 ◽  
Author(s):  
Norbert Hermanns ◽  
Dominic Ehrmann ◽  
Bernhard Kulzer

This analytical comment discusses what standards are needed for the evaluation of the accuracy of glucose measurement systems continuously measuring glucose in the interstitial fluid. Since accuracy standards for continuous glucose monitoring (CGM)/flash glucose monitoring (FGM) systems are currently based on modeling studies or consensus of experts, we raised the question whether non-inferiority trials evaluating the safety and efficacy of CGM/FGM measurements compared to capillary blood glucose measurement with point-of-care devices could help to establish clarity about the needed accuracy standards of CGM/FGM. Such trials could also support the replacement of capillary blood glucose measurements by modern CGM/FGM systems.


1999 ◽  
Author(s):  
Airat K. Amerov ◽  
Kye Jin Jeon ◽  
Yoen-Joo Kim ◽  
Gilwon Yoon

Sign in / Sign up

Export Citation Format

Share Document